W6X-33063-51893
4 vaccinations
2 coded responses
26 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 220 / VA
- Registered
- 2021-05-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-12
Dose 1 — Pfizer-BioNTech
-
2021-05-14
Registered in v-safe
- 2021-05-14
- 2021-05-15
- 2021-05-16
- 2021-05-17
-
2021-06-03
Dose 2 — Pfizer-BioNTech
-
2021-06-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache · Be unable to workAdult check-in
-
2021-06-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-06-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
-
2021-06-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2021-06-08
- 2021-06-09
- 2021-06-10
- 2021-06-19
- 2021-06-24
-
2021-07-01
Survey response — day 28, dose 2MedDRA: Dysuria, Pollakiuria, Urinary tract infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Uti; frequent urination and burningMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-01
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-06
- 2021-07-15
- 2021-09-02
-
2021-12-02
Survey response — 6 months, dose 2MedDRA: Abortion spontaneous, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Miscarriage · Healthcare visit (other): Doctor appointmentMedDRA releases: 2024-11 · check-in free text available
-
2021-12-02
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-12-03
-
2021-12-12
Dose 3 — Pfizer-BioNTech
- 2022-06-06
-
2022-09-27
Dose 4 — Pfizer-BioNTech
- 2022-09-27
- 2022-09-28
- 2022-09-29
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-03
- 2022-12-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-12 | Pfizer-BioNTech | |
| 2 | 2021-06-03 | Pfizer-BioNTech | |
| 3 | 2021-12-12 | Pfizer-BioNTech | No |
| 4 | 2022-09-27 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-01 | Unsuccessful | |
| 2021-12-02 | Unsuccessful |
Free text
Release 9 — day 28, dose 2
Symptoms: Uti; frequent urination and burning
Release 10 — 6 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Dysuria | ✓ | ✓ | ✓ |
| SD | Pollakiuria | ✓ | ✓ | ✓ |
| SD | Urinary tract infection | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release